|
|
|
|
|
|
|
Assembly Biosciences (ASMB)
|
|
46.75 0.22 (0.47%)
|
04-20 16:00
|
|
Open:
|
46.23
|
Pre. Close:
|
46.53
|
|
High:
|
47.71
|
Low:
|
45.69
|
|
Volume:
|
168,880
|
Market Cap:
|
955M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
47.734 - 47.969
|
47.969 - 48.208
|
|
Low:
|
45.148 - 45.387
|
45.387 - 45.629
|
|
Close:
|
46.362 - 46.744
|
46.744 - 47.132
|
|
|
|
Technical analysis (as of: 2018-04-20 4:27:33 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 64.42  One year: 73.77
|
|
Support:
|
Support1: 42.20 Support2: 35.11
|
|
Resistance:
|
Resistance1:
55.15 Resistance2: 63.16
|
|
Pivot:
|
46.77
|
|
Moving Averages:
|
MA(5): 46.49 MA(20): 48.37
MA(100): 49.29 MA(250): 35.85
|
|
MACD:
|
MACD(12,26):
-2.16 Signal(12,26,9): -2.21
|
|
%K %D:
|
%K(14,3): 36.31 %D(3): 28.72
|
|
RSI:
|
RSI(14): 41.96
|
|
52-Week:
|
High: 67.36
Low: 18.6 Change(%): 96.3
|
|
Average Vol(K):
|
3-Month: 21202
10-Days 29118
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.ASMB has closed above bottom band by 49.6%. Bollinger Bands are 51.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to ASMB's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-04-13T08:06:51-04:00
Premarket analyst action - healthcare
2018-04-13T08:00:00-04:00
Your Daily Pharma Scoop: Reata Provides Update, Assembly Biosciences Data, Bellicum's BPX-501
2018-04-12T06:58:03-04:00
Assembly Bio's lead candidate shows positive action in early-stage HBV studies
2018-04-11T07:06:36-04:00
Assembly Bio conference call tomorrow to review ABI-H0731 data
2018-04-06T07:14:53-04:00
Key events next week - healthcare
2018-02-14T11:00:17-05:00
Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/14/2018)
2018-02-09T12:34:12-05:00
Key events next week - healthcare
2018-01-17T12:08:19-05:00
Healthcare: The 'Week That Was' Was Good
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
